Considering the classic nuclear/genomic actions of ESR1 as a transcription factor to control gene expression [13], we aimed to investigate whether tamoxifen is involved in the modulation of DNA genomic transcription to mitigate peritoneal fibrosis. The gene discussed is ESR1; the disease is Peritoneal Fibrosis.